|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:435-439
© 2004 The American Association for Thoracic Surgery
Surgery for acquired cardiovascular disease |
a Department of Cardiac Surgery, Catholic University, Rome, Italy
Received for publication July 5, 2003; revisions received August 21, 2003; accepted for publication August 26, 2003.
* Address for reprints: Mario Gaudino, MD, Divisione di Cardiochirurgia, Policlinico Universitario A. Gemelli, Largo A. Gemelli 8, 00168 Rome, Italy
mgaudino{at}tiscali.it
| Abstract |
|---|
|
|
|---|
METHODS: Of 303 consecutive patients undergoing coronary artery bypass grafting with 3-vessel coronary disease and a dominant right coronary artery tributary of an infarcted nonischemic territory, 154 were randomized to right coronary artery revascularization and 149 to no right coronary artery grafting. In all cases, standard on-pump surgical myocardial revascularization was performed.
RESULTS: Overall hospital mortality was 2 of 154 versus 1 of 149 (P = .97); no difference in in-hospital outcome was observed between the 2 groups. At follow-up, cardiac eventfree survival was 84 of 152 in the right coronary artery grafting series and 62 of 148 in the nonright coronary artery grafting group (P = .20). However, when the analysis was limited to surviving patients without new scintigraphic evidence of ischemia (to avoid confounding factors derived from ischemia in the left coronary system or right coronary artery graft malfunction), we found that patients who received a right coronary artery graft had fewer cardiac events, a lower incidence of arrhythmia, and less left ventricular dilatation than did the nonright coronary artery revascularized series.
CONCLUSIONS: Surgical grafting of a right coronary artery tributary of an infarcted nonischemic territory in patients with 3-vessel coronary artery disease submitted to coronary artery bypass grafting improved late electric stability, ventricular geometry, and event-free survival but did not affect in-hospital or 10-year survival.
This prospective, randomized investigation was conceived to establish the effect of surgical revascularization of an infarcted nonischemic territory. To maximize homogeneity and to reduce confounding factors, we decided to isolate only the right coronary artery (RCA) as a study variable and, then, to evaluate the in-hospital and long-term effects of the surgical grafting of a dominant graftable RCA tributary of an infarcted nonischemic territory in patients with triple-vessel disease who were undergoing CABG.
| Patients and methods |
|---|
|
|
|---|
The population of the study included all patients who underwent CABG by the same surgeon at our institution from January 1990 to December 1994 and who fulfilled the following inclusion criteria at the time of operation:
Patients were then randomly assigned by the operating surgeon to receive or not receive surgical revascularization of the RCA or one of its branches, according to a computer-generated sequence. Overall, 303 of the 2506 coronary cases operated on during the study period were included: 154 were assigned to RCA revascularization, whereas 149 were assigned to no RCA grafting (Figure 1).
|
|
Follow-up
Each patient was followed up regularly at our institution 6 months after surgery and every year thereafter. At each time interval, clinical examination was performed, and the results of surface electrocardiography, stress thallium 201 myocardial scintigraphy, 24-hour Holter monitoring, and transthoracic echocardiography were carefully reviewed. Angiographic follow-up was proposed to the patients in case of scintigraphic evidence of inducible ischemia.
For the purposes of this study, all patients were telephoned and were resubmitted to clinical examination; all examinations were reviewed at the time of the follow-up. In case of death, all available clinical data were collected and reviewed by the authors to establish the cause of the fatality. Death was considered cardiac in origin when it was preceded by objective evidence of myocardial ischemia or arrhythmia and was considered noncardiac when a clear systemic or accidental cause of death was evident. Follow-up was 100% complete (300/300 surviving patients), and mean follow-up time was 119 ± 7 months.
End point definitions
Primary end points were death, cardiac death, and event-free survival (included as events: death, cardiac death, clinical angina recurrence, and new scintigraphic evidence of ischemia).
Secondary end points (to be evaluated only in surviving patients without new scintigraphic evidence of ischemia during the follow-up) were rehospitalization for heart failure, clinically evident ventricular arrhythmia, perioperative modification of left ventricular dimensions and ejection fraction, and development of new mitral insufficiency greater than or equal to grade 1+.
Statistical analysis
Data are expressed as mean ± SD. Statistical analysis comparing 2 groups was performed with unpaired 2-tailed t testing for the means or with the
2 test for categorical variables.
To avoid bias related to RCA graft malfunction in the RCA revascularization group and in an attempt to isolate the effect of RCA revascularization alone and minimize confounding factors related to ischemia in the left coronary system, we performed a separate comparison of follow-up data with the exclusion of all patients in whom new scintigraphic evidence of ischemia developed during the follow-up period. Analysis was conducted by the software Statistica for Windows 4.1 (StatSoft Inc, Tulsa, Okla).
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Although some interventional cardiologist groups reported good results, doubts about the efficacy of this limited revascularization policy have been elicited by several authors, and the results of this strategy applied to surgical revascularization procedures were never investigated in detail.4-7 Our study was designed with the aim of establishing the immediate and long-term effects of surgical grafting of a vessel tributary of an infarcted nonischemic (scarred) myocardial territory.
Because the heterogeneity of patients with coronary artery disease submitted to CABG renders extremely difficult the task of avoiding confounding factors in the elaboration of a comparison between different treatments, every effort was made to minimize potential bias. First, a prospective randomized design was judged necessary. Moreover, the operating surgeon and the surgical technique were always the same to avoid a technical influence on postoperative results. Similarly, to maximize the homogeneity of the study population, we isolated only the RCA as a study variable. Moreover, to eliminate the potential confounding factors related to ischemia in the left coronary system or RCA graft malfunction among RCA-revascularized patients, we added to the analysis of the results of the overall population a separate analysis of the follow-up data with the exclusion of all patients in whom new scintigraphic evidence of ischemia developed during the years after surgery.
Using this method, we found that RCA-revascularized and nonRCA-revascularized patients had similar postoperative outcomes and did not significantly differ in crude survival in the 10 years after surgery. However, RCA-revascularized patients exhibited a trend toward better long-term cardiac eventfree survival (84/152 vs 62/148); because statistical significance could have been limited by the sample size in our series, it is possible that future larger multi-institutional studies could more clearly demonstrate significant clinical benefits related to RCA grafting. Moreover, RCA revascularization was associated with increased electrophysiological stability and less left ventricular dilatation, as evidenced by the higher incidence of arrhythmia, cardiac events, and heart failure, larger left ventricular volumes, and higher incidence of new mitral regurgitation in the series of patients in whom the RCA was left ungrafted (Table 3).
Clinical and experimental studies have suggested that the benefits of reperfusion of an infarct-related artery extend beyond the simple salvage of ischemic myocardium and favorably affect left ventricular remodeling and electrical stability independently from the functional status of the infarcted myocardium (the open artery hypothesis).8-13 Our observations are in accordance with those data and seem to establish the superiority of anatomically complete versus functionally adequate revascularization for patients with triple-vessel disease submitted to CABG (at least in regard to the RCA).
These findings are of particular relevance at a time when the growing diffusion of minimally invasive techniques and beating-heart surgery has led to an increasing acceptance by the surgical community of a revascularization strategy limited to ischemic myocardial areas.14 Although we have no information on the effect of revascularization of left coronary system branches feeding into a scar territory, the larger amount of myocardium supplied by the left coronary system should theoretically render the advantages observed for the RCA even more evident.
While waiting for objective verification of this hypothesis, we can conclude that surgical grafting of an RCA tributary of an infarcted nonischemic territory in patients with 3-vessel disease submitted to CABG improves late electric stability and ventricular remodeling and reduces rehospitalization for cardiac events, although it does not affect in-hospital or 10-year survival. Surgical grafting of a diseased RCA should, then, always be attempted, independently from the functional status of the myocardium supplied by the artery.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Pocar, E. Quaini, and F. Donatelli Letter by Pocar et al Regarding Article, "Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience" Circulation, November 7, 2006; 114(19): e574 - e574. [Full Text] [PDF] |
||||
![]() |
A. Chieffo, N. Morici, J. Cosgrave, M. Montorfano, F. Airoldi, M. Carlino, I. Michev, G. Melzi, G. Sangiorgi, A. Colombo, et al. Response to Letters Regarding Article, "Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience" Circulation, November 7, 2006; 114(19): e575 - e575. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |